Neuroprosthetic Device for Improving Issues Caused by Diabetic Neuropathy With Specifically Designed Neural Stimulation

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorInstitute Mihajlo Pupin

About this trial

Neuropathy refers to a condition that results from damage to the peripheral nerves.The most common cause of it is diabetes mellitus, metabolic disorder that affects more than 422 million individuals worldwide, putting a huge strain on the healthcare system and up to 50% of these individuals will develop neuropathy. Peripheral neuropathy is characterized by sensory nerve abnormalities such as an impaired sense of touch. Sensory loss in feet can lead to functional deficits during gait, low balance, and increased risk of falls and is considered the strongest risk factor for diabetic foot ulceration. Moreover, these patients usually also suffer from neuropathic pain, which is believed to be associated with aberrant sensory input.

With this in mind, the study aims to understand the effects of restoring sensation lost to neuropathy using transcutaneous electrical stimulation. Additionally, the investigators aim to understand if electrical stimulation of the damaged nerves can reduce health consequences such as chronic pain.

To achieve this, the investigators have developed a wearable sensory restoration system that can restore lost sensation with non-invasive, precisely controlled electrical stimulation through electrodes integrated into the sock garment. A system is composed of a system controller that communicates via Bluetooth with force-sensitive insoles placed in the shoes and neurostimulators directly connected to electrode array socks. Based on the insole recordings the stimulation parameters are defined in real-time, making it a closed-loop system for restoring somatotopic sensory feedback.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Diagnosed polyneuropathy

Ability to stand and walk unassisted.

Sensory loss in the feet

Disqualifiers

Open ulcers on the feet

Pregnancy

History of or current psychological diseases that include schizophrenia and major depression

Hypersensitivity to electrical stimulation

Trial design

Design model

Single group

Treatments tested in this trial

  • Somatosensory feedback

    Device

    Performing different mobility tasks in 10 separate sessions while the device is providing or not somatotopic sensations through non-invasive electrical stimulation. Benefits connected to the stimulation of sensory nerves will be assessed.

Treatment groups

20 Participants
are divided into 1 treatment group
Group A: Somatosensory feedbackExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Location of evoked sensations

Document where on the feet the subject perceives the stimulation locations.

Time frame
through study completion, an average of 2 weeks
2

Stimulation threshold range to a variety of stimulus parameters

Quantify the lower and higher threshold (charge) stimulus eliciting somatosensory sensation

Time frame
through study completion, an average of 2 weeks
3

Safety of the participants

Number of adverse events possibly, probably or causally related to the procedure or device

Time frame
up to 1.5 months

Secondary outcomes

1

Impact of providing somatosensory feedback on mobility

Demonstration of statistically relevant change of kinematic parameter (m/s) while performing mobility tests (climbing and descending stairs, 10 meter walking test, 6 minutes walking test etc.) with provided sensory feedback compared to the case without the provided sensory feedback.

Time frame
through study completion, an average of 2 weeks
2

Impact of providing somatosensory feedback on balance

Demonstration of statistically relevant change of score in 4-stage balance test with open eyes with provided sensory feedback compared to the case without the provided sensory feedback.

Time frame
through study completion, an average of 2 weeks
3

Impact of providing somatosensory feedback on balance

Demonstration of statistically relevant change of score in 4-stage balance test with closed eyes with provided sensory feedback compared to the case without the provided sensory feedback.

Time frame
through study completion, an average of 2 weeks
4

Impact of providing sensory feedback on neuropathic pain from pre treatment to post treatment

Demonstrating the change in level of neuropathic pain using Neuropathic pain symptoms inventory (NPSI) questionnaire. It will be assessed before starting the treatment, every session of the treatment, one day after the last session, one week after the last session, one month after the last session

Time frame
up to 1.5 month

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Institute Mihajlo Pupin

Lead sponsor

Clinical Centre of Serbia

Collaborator

University of Belgrade

Collaborator

ETH Zurich

Collaborator